Dysfunctional telomeres and dyskeratosis congenita

Haematologica

Volumn 92, Issue 8, 2007, Pages 1009-1012

  Bessler, Monica ^a   Du, Hong Yon ^a   Gu, Baiwei ^a   Mason, Philip J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE BETA; DYSKERIN; RIBONUCLEOPROTEIN; TELOMERASE; CELL CYCLE PROTEIN; DKC1 PROTEIN, HUMAN; NUCLEAR PROTEIN; RNA; TELOMERASE RNA; TERT PROTEIN, HUMAN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AUTOSOMAL DOMINANT INHERITANCE; BONE MARROW DEPRESSION; CANCER CELL; CELL CYCLE ARREST; CELL DEATH; CELL DIVISION; CELL GROWTH; CELL SURVIVAL; CEREBELLUM HYPOPLASIA; CHROMOSOME; CHROMOSOME MUTATION; CLINICAL FEATURE; DISEASE SEVERITY; DNA STRAND; DYSKERATOSIS CONGENITA; EDITORIAL; ENZYME ACTIVITY; GENE MUTATION; HETEROZYGOTE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MENTAL DEFICIENCY; MICROCEPHALY; MOLECULAR CLOCK; PROTEIN STRUCTURE; SOMATIC CELL; T LYMPHOCYTE; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; X CHROMOSOME INACTIVATION; DOMINANT GENE; FEMALE; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETICS; MALE; METABOLISM; MUTATION; NOTE; PHENOTYPE; PHYSIOLOGY; ULTRASTRUCTURE;

ANTICIPATION, GENETIC; CELL CYCLE PROTEINS; DYSKERATOSIS CONGENITA; FEMALE; GENES, DOMINANT; GENETIC HETEROGENEITY; HUMANS; MALE; MUTATION; NUCLEAR PROTEINS; PHENOTYPE; RNA; TELOMERASE; TELOMERE;

EID: 35748940022     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11221     Document Type: Editorial

References (33)

1. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
2. de Lange T. Protection of mammalian telomeres. Oncogene 2002;21:532-40.
3. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-60.
4. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996;18:173-9.
5. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994;91:9857-60.
6. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-13.
7. Shay JW, Zou Y, Hiyama E, Wright WE. Telomerase and cancer. Hum Mol Genet 2001;10:677-85.
8. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-8.
9. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114-8.
10. Rufer N, Brummendorf TH, Kolvraa S, Bischoff C, Christensen K, Wadsworth L, et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 1999; 190:157-67.
11. Mitchell JR, Cheng J, Collins K. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end. Mol Cell Biol 1999;19:567-76.
12. Marciniak RA, Johnson FB, Guarente L. Dyskeratosis congenita, telomeres and human ageing. Trends Genet 2000;16:193-5.
13. Vulliamy TJ, Knight SW, Mason PJ, Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 2001;27:353-7.
14. Cole H, Rauschkolb J, Toomey J. Dyskeratosis congenita with pigmentation, dystrophia unguis and leukokeratosis oris. Arch Derm Syph Suppl 1930;21:71-95.
15. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 2000;110:768-79.
16. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR. Protein composition of catalytically active human telomerase from immortal cells. Science 2007;315:1850-3.
17. Vulliamy TJ, Knight SW, Dokal I, Mason PJ. Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. Blood 1997;90:2213-6.
18. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999;402:551-5.
19. Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood 2006;107:2680-5.
20. Meier UT. The many facets of H/ACA ribonucleoproteins. Chromosoma 2005;114:1-14.
21. He J, Navarrete S, Jasinski M, Vulliamy T, Dokal I, Bessler M, et al. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene 2002; 21:7740-4.
22. Mochizuki Y, He J, Kulkarni S, Bessler M, Mason PJ. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci USA 2004;101:10756-61.
23. Wong JM, Collins K. Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev 2006;20:2848-58.
24. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001;413:432-5.
25. Yamaguchi H, Calado RT, Ly H, Kajigaya S, Baerlocher GM, Chanock SJ, et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med 2005;352:1413-24.
26. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007; 356:1317-26.
27. Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, Weissler JC, et al. Adult-onset pulmonary fibrosis caused by telomerase mutations. Pro Nat Acad Sci USA 2007; 104:7552-7.
28. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 2004;36:447-9.
29. Goldman F, Bouarich R, Kulkarni S, Freeman S, Du HY, Harrington L, et al. The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci USA 2005;102:17119-24.
30. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91:25-34.
31. Liu Y, Snow BE, Hande MP, Yeung D, Erdmann NJ, Wakeham A, et al. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol 2000;10:1459-62.
32. Armanios M, Chen JL, Chang YP, Brodsky RA, Hawkins A, Griffin CA, et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA 2005;102:15960-4.
33. Marrone A, Sokhal P, Walne A, Beswick R, Kirwan M, Killick S, et al. Functional characterization of novel telomerase RNA (TERC) gene mutations in patients with diverse clinical and pathological presentations. Haematologica 2007;92:1013-20.